AI
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
Also, insurtech company Huize from China is expanding to Southeast Asia.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Cloudphysician targets to enter the United States, the Middle East, and Southeast Asia with its smart ICU and emergency department solutions.
The New York-based company will use the funds to grow its team, continue expanding into health systems and accelerate product innovation.
Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.
Interestingly, young physicians see more risk to it than their senior counterparts.
It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.